Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Anselmo

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 24, 2002
FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltrationDean M Anselmo, Farin F Amersi, Xiu-Da Shen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 24, 2004
Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis CMitsugi Shimoda, Rafik M Ghobrial, Ian C Carmody, et al.
Annals of Surgery|June 24, 1998
Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1T S Dulkanchainun, J A Goss, D K Imagawa, et al.
Annals of Surgery|May 2, 2003
Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year periodDouglas G Farmer, Dean M Anselmo, R Mark Ghobrial, et al.
Annals of Surgery|May 1, 2002
New era of liver transplantation for hepatitis B: a 17-year single-center experienceDean M Anselmo, Rafik M Ghobrial, Lee Chan Jung, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2006
A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirinA Ciancio, A Picciotto, C Giordanino, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 24, 2002
FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltrationDean M Anselmo, Farin F Amersi, Xiu-Da Shen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 24, 2004
Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis CMitsugi Shimoda, Rafik M Ghobrial, Ian C Carmody, et al.
Annals of Surgery|June 24, 1998
Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1T S Dulkanchainun, J A Goss, D K Imagawa, et al.
Annals of Surgery|May 2, 2003
Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year periodDouglas G Farmer, Dean M Anselmo, R Mark Ghobrial, et al.
Annals of Surgery|May 1, 2002
New era of liver transplantation for hepatitis B: a 17-year single-center experienceDean M Anselmo, Rafik M Ghobrial, Lee Chan Jung, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2006
A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirinA Ciancio, A Picciotto, C Giordanino, et al.
Pageof 6